Gene Query: MEA1

Dataset Description Geneva Score
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 63.94
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 29.61
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 29.49
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 23.81
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 16.63
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 16.49
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 16.43
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 15.79
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 15.47
Transcriptomic analysis of human tonsillar TFH subsets 15.05
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 14.81
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 14.69
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 14.56
Fbxo32 mediated gene expression program underlies EMT and metastasis 14.49
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 14.44
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 14.39
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 14.38
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 14.3
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 14.06
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 14.06
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 13.59
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 13.35
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 13.35
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 13.3
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 13.3
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 13.13
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 13.0
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 12.73
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 12.46
Regulatory network controlling tumor-promoting inflammation in human cancers 12.46
Differential gene expression of human melanoma cells [RNA-seq] 12.43
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 12.43
hTERT promotes cell adhesion and migration independent of telomerase activity 12.39
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 12.33
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 12.05
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 11.96
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 11.94
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 11.79
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 11.66
HEK293 Heat-shock experiment 11.66
Transcriptome analysis of SKI knock-out in HL60 cells 11.41
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 11.41
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 11.37
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 11.37
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 11.11
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 11.0
Global transcriptome analysis of HAP1 cells 10.99
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 10.79
DART-seq: an antibody-free method for global m6A detection 10.56
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 10.52
Peptidomimetic blockade of MYB in acute myeloid leukemia 10.5
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 10.5
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 10.41
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 10.41
METTL3 promotes translation in human cancer cells 10.41
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 10.29
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 10.25
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 10.25
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 10.2
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 10.14
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 10.12
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 10.12
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 10.07
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 10.07
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 10.03
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 10.03
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.0
Global analysis of enhancer targets: Mosaic-seq 9.99
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 9.83
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 9.83
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 9.82
Rorc disruption in human FG pancreatic cancer cells 9.75
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 9.64
Gene expression changes caused by KRAS in MCF-10A 9.52
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 9.51
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 9.5
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 9.49
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 9.43
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 9.41
Stem and effector CD8 T-cells from human cancers 9.37
miRNAs affected by antagomiR-17 treatment 9.32
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 9.22
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 9.22
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 8.93
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 8.93
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 8.93
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.92
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 8.91
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 8.91
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 8.85
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 8.85
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 8.78
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 8.76
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 8.73
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 8.73
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 8.65
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 8.43
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 8.41
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 8.4
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 8.4
miR941 overexpression experiment 8.39
Paxillin regulates genomic networks in prostate cancer [LNCaP] 8.35
H1609088 Human RNA-Sequencing 8.3
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 8.28
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 8.23
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 8.14
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 8.14
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 8.12
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 8.12
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 8.08
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 8.07
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 8.07
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 7.96
IMP3 regulated gene expression in breast cancer cells 7.91
CROP-Seq in Primary Human T Cells 7.89
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 7.82
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 7.79
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 7.78
Inhibition of TNBC metastasis by Gpx1 7.77
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 7.75
Transcriptome analysis of U87 cells upon LINC00152 knockdown 7.74
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 7.73
Identification of global regulators of T-helper cell lineage specification 7.73
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 7.71
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 7.65
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 7.62
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 7.61
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 7.58
Impact of dieldrin on transcription in Jurkat T cells 7.56
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 7.53
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 7.53
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 7.53
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 7.47
Conservative alteration of chromosomal expression pattern across human solid tumor types 7.38
Differentiation enhances Zika virus infection in neuronal brain cells 7.38
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.34
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 7.33
HNF1A deficiency impairs β-cell fate, granule maturation and function 7.32
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 7.28
Transcriptome analysis upon C6orf203 silencing 7.26
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.26
Comprehensive comparative analysis of 5’ end RNA sequencing methods 7.2
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 7.14
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 7.14
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 7.13
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 7.11
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.09
Genome wide expression change in LCC2 and MCF-7 cells 7.08
The comparison of high-throughput single-cell RNA-seq methods 6.94
Ribosomal footprinting of CN34-Parental and CN34-LM1a 6.9
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 6.88
MOF acetyl transferase regulates transcription and respiration in mitochondria 6.87
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 6.85
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 6.83
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 6.82
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 6.81
The evolution of N6-methyladenosine in primates 6.76
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 6.74
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 6.69
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 6.67
LncRNA-GAS5 negative regulation of YAP-target genes expression 6.63
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 6.62
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 6.62
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 6.6
Cleavage Factor Im as a key regulator of 3’ UTR length 6.57
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 6.56
An integrative analysis of non-coding regulatory DNA variations associated with autism 6.52
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 6.49
Expression by CD133+ cells isolated from the adult human exocrine pancreas 6.47
scRNASeq analysis of cycling cardiomyocytes 6.46
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 6.43
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 6.42
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 6.41
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 6.41
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 6.39
High-throughput sequencing of pluripotent cells 6.38
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 6.38
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 6.36
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 6.3
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 6.27
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 6.25
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 6.22
RNA-Seq with and without RNase treatment in PCa cell lines 6.2
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 6.17
single cell RNA-seq from GM12878 (ENCSR673UIY) 6.14
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 6.13
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 6.13
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 6.11
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 6.06
Gene expression in PANC1 cells treated with Rakicidin 6.0
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 5.99
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 5.98
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 5.97
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 5.97
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 5.93
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 5.92
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 5.85
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 5.85
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 5.83
Gene induction by the USP6 oncogene in response to interferon 5.82
Transcriptomic analysis of the HOTAIR-regulated genes 5.7
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 5.66
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 5.66
Genes significantly down or Up-regulated upon RNF219 knockdown 5.63
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 5.62
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 5.6
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 5.58
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 5.57
MicroRNA-125a-5p overexpression in human macrophages 5.55
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 5.51
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 5.51
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 5.51
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 5.48
Iron response of HepG2 cells 5.47
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 5.47
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 5.45
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 5.44
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 5.36
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 5.35
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 5.31
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 5.31
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 5.3
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 5.3
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 5.3
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 5.28
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 5.25
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 5.25
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 5.22
RNA editing in nascent RNA affects pre-mRNA splicing 5.21
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 5.17
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 5.15
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 5.14
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 5.09
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 5.05
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 5.04
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 5.0
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 5.0
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 5.0
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 4.98
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.98
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 4.97
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 4.95
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.95
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 4.95
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 4.94
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 4.92
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 4.9
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.89
Gene expression and genome-wide location analysis of breast cancer cell-lines 4.89
Gene expression analysis of breast cancer cell-lines 4.89
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 4.85
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 4.83
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 4.83
Determining mRNA half-lives on a transcriptome-wide scale 4.81
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 4.79
Effect of PRDM11 depletion in U2932 cells 4.79
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.77
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 4.75
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 4.75
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 4.68
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 4.66
Novel Targeting of Transcription and Metabolism in Glioblastoma 4.62
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 4.55
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 4.55
RNA-seq analysis of control and Myc-induced U2OS cells 4.5
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 4.47
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 4.45
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 4.41
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 4.41
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 4.39
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.38
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 4.34
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 4.34
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 4.32
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 4.29
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 4.29
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 4.26
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.25
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 4.21
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 4.12
Identification of renal resident macrophages across species 4.06
RNA-sequencing of healthy human skeletal myocytes 4.04
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.04
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 4.04
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 4.04
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 4.03
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 4.02
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 4.02
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 3.96
Functional significance of the HIV-1 Tat signature amino acid residues 3.95
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 3.94
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 3.9
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 3.9
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 3.9
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 3.89
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 3.89
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 3.81
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 3.8
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 3.8
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.79
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.79
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 3.75
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 3.68
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 3.67
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 3.67
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 3.67
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 3.64
O-glcnAc reprograms cellular energetics 3.63
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 3.63
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 3.63
Real-time observation of light-controlled transcription in living cells 3.62
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.61
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.6
Total RNA-seq in ALL-SIL upon TLX1 knockdown 3.59
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 3.55
Interaction between mitoNEET and NAF-1 in cancer cells 3.45
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 3.45
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 3.44
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 3.44
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 3.43
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 3.42
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 3.38
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 3.36
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 3.36
Ribosome profiling upon inhibition of eIF4A 3.35
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.35
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.3
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 3.26
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.23
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 3.19
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 3.16
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.16
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 3.15
Triple vectors expand AAV transfer capacity in the retina 3.15
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 3.14
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 3.14
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 3.14
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.13
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.13
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 3.11
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 3.1
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 3.07
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 3.07
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 3.07
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.05
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 3.05
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 3.03
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 3.02
RNAseq of cell lines with knocked in ESR1 mutations 2.99
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.93
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.92
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.92
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.9
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 2.88
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 2.88
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.83
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.83
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.77
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.76
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 2.72
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 2.71
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 2.66
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 2.62
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.61
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.59
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 2.58
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 2.58
RNA-seq analysis upon ARID1B overexpression 2.57
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 2.54
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 2.53
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  2.49
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 2.49
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 2.44
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.44
Human Treg IFNg/IL-10 subpopulations 2.4
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.3
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 2.27
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.22
A20 regulates canonical wnt-signaling through an interaction with RIPK4 2.21
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 2.16
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 2.14
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.13
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 2.11
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 2.09
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 2.08
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.07
N6-methyladenine DNA Modification in Glioblastoma 2.07
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.07
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.06
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.03
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.01
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.99
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.97
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 1.94
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.89
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.86
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.84
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.84
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.83
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.81
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.79
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.79
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 1.77
The transcriptome effect of overexpressing EZH2 in MCF7 1.76
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 1.72
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.72
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.72
p53 activity results in DNA replication fork processivity 1.71
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.68
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.68
Genome-wide analysis of the Integrator complex 1.57
Genome-wide analysis of the Integrator complex (HTS) 1.57
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.46
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.42
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.41
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.41
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.36
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 1.31
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 1.31
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 1.29
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.28
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.26
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.23
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 1.22
Effect of ILF3 on translation during homeostasis and the antiviral response 1.22
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.21
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 1.21
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 1.21
Global transcriptome analysis of WT versus HEB-/- hESCs 1.21
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.2
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.19
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 1.17
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.15
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 1.14
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.11
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.11
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.09
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 1.06
FBXW7 modulates stress response by post-translational modification of HSF1 1.06
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.05
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.05
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 0.99
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 0.99
Metabolism as an early predictor of DPSCs aging 0.98
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.96
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 0.95
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.92
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.91
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.87
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.87
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.87
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.87
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.86
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.81
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.79
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.78
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.78
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.76
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.75
High-resolution comparative analysis of great ape genomes 0.71
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.68
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.67
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 0.66
Effect of BMP inhibition or stimulation of primary human keratinocytes 0.66
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.65
The DPYSL2 gene connects mTOR and schizophrenia 0.63
Single-cell analysis of human kidney organoids 0.61
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.59
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.59
Identification of renal resident macrophages across species [C1] 0.58
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.56
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.54
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.43
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.41
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.41
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.4
The cohesin complex prevents Myc-induced replication stress 0.39
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.39
The circadian transcriptional landscape in primary human mammary epithelial cells 0.36
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.34
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.33
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.33
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.31
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.3
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 0.29
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.28
Effects of transcription on genome - nuclear lamina interactions 0.28
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.22
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.17
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.17
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.16
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.14
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.14
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.07
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 0.06
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.06
siRNA-mediated knockdown 0.05
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.05
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.01
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation